In contrast to WT mice, IL-17A−/− mice were protected and did not develop anti-MPO GN, which was attributed to the reduced neutrophil infiltration and subsequent decrease in the deposition of glomerular MPO [112]. The gene discussed is MPO; the disease is ganglioneuroma.